WallStSmart

Accenture plc (ACN)vsConcentrix Corporation (CNXC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Accenture plc generates 631% more annual revenue ($73.10B vs $10.00B). ACN leads profitability with a 10.7% profit margin vs -13.2%. CNXC appears more attractively valued with a PEG of 0.32. ACN earns a higher WallStSmart Score of 69/100 (B-).

ACN

Strong Buy

69

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 8.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.79

CNXC

Buy

60

out of 100

Grade: C+

Growth: 7.3Profit: 4.0Value: 8.3Quality: 4.0
Piotroski: 4/9Altman Z: 0.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACNUndervalued (+23.0%)

Margin of Safety

+23.0%

Fair Value

$200.02

Current Price

$163.29

$36.73 discount

UndervaluedFair: $200.02Overvalued
CNXCUndervalued (+62.7%)

Margin of Safety

+62.7%

Fair Value

$93.25

Current Price

$26.56

$66.69 discount

UndervaluedFair: $93.25Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACN5 strengths · Avg: 9.0/10
P/E RatioValuation
11.3x10/10

Attractively priced relative to earnings

Market CapQuality
$85.73B9/10

Large-cap with strong market position

Return on EquityProfitability
24.5%9/10

Every $100 of equity generates 25 in profit

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

Free Cash FlowQuality
$3.60B8/10

Generating 3.6B in free cash flow

CNXC3 strengths · Avg: 9.3/10
PEG RatioValuation
0.3210/10

Growing faster than its price suggests

Price/BookValuation
0.6x10/10

Reasonable price relative to book value

EPS GrowthGrowth
36.1%8/10

Earnings expanding 36.1% YoY

Areas to Watch

ACN1 concerns · Avg: 3.0/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

CNXC4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

Market CapQuality
$1.49B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.703/10

Elevated debt levels

Return on EquityProfitability
-47.6%2/10

ROE of -47.6% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : ACN

The strongest argument for ACN centers on P/E Ratio, Market Cap, Return on Equity. PEG of 1.02 suggests the stock is reasonably priced for its growth.

Bull Case : CNXC

The strongest argument for CNXC centers on PEG Ratio, Price/Book, EPS Growth. PEG of 0.32 suggests the stock is reasonably priced for its growth.

Bear Case : ACN

The primary concerns for ACN are Piotroski F-Score.

Bear Case : CNXC

The primary concerns for CNXC are Revenue Growth, Market Cap, Debt/Equity. Debt-to-equity of 1.70 is elevated, increasing financial risk.

Key Dynamics to Monitor

ACN profiles as a value stock while CNXC is a turnaround play — different risk/reward profiles.

ACN carries more volatility with a beta of 1.12 — expect wider price swings.

ACN is growing revenue faster at 5.6% — sustainability is the question.

ACN generates stronger free cash flow (3.6B), providing more financial flexibility.

Bottom Line

ACN scores higher overall (69/100 vs 60/100). CNXC offers better value entry with a 62.7% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accenture plc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.

Concentrix Corporation

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Concentrix Corporation offers global technology customer experience solutions. The company is headquartered in Fremont, California.

Visit Website →

Want to dig deeper into these stocks?